Study guide

16.3 Pelvic Inflammatory Disease

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

16.3 Pelvic Inflammatory Disease

Key Takeaways Explain This Topic AI

Empiric treatment is started for pelvic pain with any one of cervical motion tenderness, uterine tenderness, or adnexal tenderness, because the threshold is deliberately low.

Up to 60 to 70 percent of cases are polymicrobial, involving anaerobes, Mycoplasma genitalium, and enteric organisms beyond gonorrhea and chlamydia.

Hospitalization is required for pregnancy, tubo-ovarian abscess, inability to tolerate oral therapy, severe illness, failed outpatient therapy, or a surgical emergency that cannot be excluded.

One episode of PID roughly doubles the risk of ectopic pregnancy and causes tubal factor infertility in a substantial minority of patients.

Fitz-Hugh-Curtis syndrome is perihepatitis from ascending infection, producing right upper quadrant pain and violin-string adhesions.

Last updated: September 2026

Pelvic Inflammatory Disease (PID)

Pelvic Inflammatory Disease (PID) is an ascending, polymicrobial infection of the upper female genital tract, encompassing any combination of endometritis , salpingitis , tubo-ovarian abscess (TOA) , and pelvic peritonitis . While N. gonorrhoeae and C. trachomatis are classic initiators, up to 60% to 70% of clinical cases are polymicrobial, involving vaginal anaerobes ( Prevotella , Bacteroides ), Mycoplasma genitalium , and enteric Gram-negative rods. Pelvic Inflammatory Disease Diagnostic & Triage Pathway

  • ├── Presumptive Minimum Clinical Criteria (At Least One Required with Pelvic Pain)
  • │ ├── 1. Cervical Motion Tenderness ("Chandelier Sign")
  • │ ├── 2. Uterine Fundal Tenderness
  • │ └── 3. Adnexal Tenderness (Unilateral or Bilateral)
  • ├── Additional Supportive Criteria (Enhance Diagnostic Specificity)
  • │ ├── Oral Temperature >38.3°C (101.0°F)
  • │ ├── Abnormal Cervical Mucopurulent Discharge or Friability
  • │ ├── Abundant WBCs on Saline Vaginal Wet Mount (>10–20/HPF)
  • │ ├── Elevated Inflammatory Markers (ESR or C-Reactive Protein)
  • │ └── Positive NAAT for Neisseria gonorrhoeae or Chlamydia trachomatis
  • └── Triage: Inpatient Admission vs. Outpatient Management
  • ├── Inpatient Indications: Surgical emergency not ruled out, Tubo-Ovarian Abscess,
  • │ Pregnancy, Severe illness/peritonitis, Inability to tolerate oral fluids, Failed outpatient
  • └── Outpatient Regimen: Ceftriaxone 500 mg IM + Doxycycline 100 mg BID x 14d + Metronidazole 500 mg BID x 14d

└── MANDATORY: Clinical Reassessment within 48 to 72 Hours!

CDC Diagnostic Threshold (The "Low Bar" Rule)

Because irreversible tubal scaring occurs rapidly with subclinical or delayed therapy, the CDC mandates that clinicians maintain a low threshold for diagnosis and empiric treatment . Empiric antimicrobial therapy for PID must be initiated immediately in any sexually active young female presenting with lower abdominal or pelvic pain if no cause other than PID can be identified , and at least one of the following three minimum clinical criteria is present on bimanual pelvic examination:

Cervical Motion Tenderness (CMT): Exquisite pain elicited when the cervix is mobilized laterally during bimanual exam ("chandelier sign").

Uterine Tenderness: Pain upon direct bimanual palpation and compression of the uterine fundus.

Adnexal Tenderness: Direct palpation tenderness over one or both ovaries and fallopian tubes.

Outpatient Treatment Regimen

Patients who are hemodynamically stable, tolerating oral fluids, and have no evidence of tubo-ovarian abscess or peritonitis are managed in the outpatient setting:

  • Ceftriaxone 500 mg IM in a single dose (1 g if weight ≥150 kg), PLUS
  • Doxycycline 100 mg PO BID for 14 days , PLUS

Metronidazole 500 mg PO BID for 14 days .

Midwifery Rationale for Metronidazole: Metronidazole is mandatory to ensure complete anaerobic coverage and eradicate Trichomonas vaginalis , substantially reducing upper genital tract epithelial damage and chronic tubal scarring.

The 48- to 72-Hour Rule: Outpatient management demands a mandatory clinical re-examination within 48 to 72 hours . If the patient demonstrates significant clinical improvement (defervescence, reduced pelvic tenderness, improved mobility), outpatient oral therapy is continued to complete the full 14-day course. If the patient has failed to improve or has worsened, immediate hospitalization for parenteral therapy and diagnostic imaging is required.

Inpatient Hospital Admission Criteria

Immediate hospital admission for parenteral broad-spectrum antibiotic therapy is required if:

Surgical emergencies (e.g., acute appendicitis, ruptured ovarian cyst, ectopic pregnancy) cannot be definitively excluded.

Suspected or ultrasound-confirmed Tubo-Ovarian Abscess (TOA) .

Pregnancy: Pregnant individuals with PID face extreme risks of maternal sepsis, second-trimester loss, and preterm delivery; inpatient IV therapy is mandatory.

Severe illness, high fever (>38.5°C), persistent nausea, vomiting, or peritoneal signs (rebound tenderness, involuntary guarding).

Clinical failure of oral outpatient therapy after 48 to 72 hours.

Inability to tolerate, adhere to, or absorb outpatient oral regimens.

Long-Term Sequelae of PID

Tubal Factor Infertility: Post-infectious salpingitis produces mucosal deciliation and luminal occlusion. The risk of permanent tubal infertility escalates exponentially with each subsequent episode: ~10% to 12% after a single episode , ~20% to 25% after two episodes , and ≥50% after three or more episodes .

Ectopic Pregnancy: Endosalpingeal damage and intraluminal synechiae impede normal blastocyst transit, conferring a 6- to 10-fold increase in the risk of ectopic gestation.

Chronic Pelvic Pain: Affects up to 30% of women, driven by extensive pelvic fibrous adhesions, hydrosalpinx, and recurrent pelvic congestion.

Fitz-Hugh-Curtis Syndrome (Perihepatitis): Ascending transperitoneal tracking of infected exudate along the paracolic gutters into the subdiaphragmatic space. Manifests with severe, pleuritic right upper quadrant (RUQ) abdominal pain radiating to the right shoulder, friction rub over the liver, and normal liver transaminases. Laparoscopy demonstrates pathognomonic "violin-string" fibrinous adhesions between the anterior hepatic capsule and the peritoneal abdominal wall.

Differential Diagnosis

The low diagnostic threshold for PID means empiric treatment begins before certainty — but it does not license skipping the differential, because two of the alternatives are surgical emergencies:

Condition Distinguishing features

Ectopic pregnancy Positive pregnancy test, amenorrhea, unilateral pain. A pregnancy test is mandatory in every patient evaluated for PID — this is the one test that must never be deferred

Appendicitis Pain migrating from periumbilical to the right lower quadrant, anorexia, rebound tenderness, usually without cervical motion tenderness or discharge

Ovarian torsion Abrupt, severe, unilateral pain with nausea and vomiting; an adnexal mass with absent or diminished Doppler flow

Ruptured or hemorrhagic ovarian cyst Sudden pain often at midcycle or after intercourse, without fever or discharge

Urinary tract infection or pyelonephritis Dysuria and frequency, costovertebral angle tenderness, abnormal urinalysis

Endometriosis Cyclic, chronic pain with dysmenorrhea and dyspareunia, without fever or acute inflammatory markers

The 72-Hour Rule & Treatment Failure

Re-evaluate every outpatient within 72 hours . Substantial clinical improvement — defervescence, reduced abdominal and adnexal tenderness, reduced cervical motion tenderness — should be evident by then.

Failure to improve within 72 hours requires hospitalization, parenteral therapy, and further imaging to look for a tubo-ovarian abscess or an alternative diagnosis. Continuing oral therapy and "giving it more time" in a patient who is not improving is the classic tested error.

Intrauterine Devices

Do not reflexively remove an IUD in a patient diagnosed with PID. Begin treatment with the device in place and reassess at 48 to 72 hours; removal is considered only if there is no clinical improvement. The historical association between IUDs and PID is largely confined to the first 3 weeks after insertion , when a pre-existing cervical infection can be carried upward; beyond that window the device does not raise the risk.

Partner Management & Follow-Up

Treat sexual partners from the preceding 60 days — or the most recent partner if the last contact was longer ago — for gonorrhea and chlamydia, regardless of the partner's symptoms or test results. Use expedited partner therapy where state law permits it.

Abstain from intercourse until both the patient and all partners have completed therapy and are symptom-free.

Retest for gonorrhea and chlamydia at 3 months after treatment. This is a test for reinfection , which is common, not a test of cure — and it is the follow-up step most often omitted.

Use the visit to offer HIV and syphilis testing, HIV pre-exposure prophylaxis counseling, HPV vaccination if indicated, and contraception , since a patient presenting with PID is by definition in a window of elevated sexual-health risk.